HRT Financial’s CNS Pharmaceuticals CNSP Stock Holding History

HRT Financial’s Portfolio CNSP Stock Details CNSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-905	Closed	-$8K	–	2958
2025 Q2	$8K	Buy	+905	New	+$11.3K	﹤0.01%	2464
2025 Q1	–	Sell	-260	Closed	-$18K	–	2620
2024 Q4	$18K	Buy	+260	New	+$18.5K	﹤0.01%	2219
2024 Q2	–	Sell	-1	Closed	-$7K	–	2331
2024 Q1	$7K	Buy	+1	New	+$14.5K	﹤0.01%	2091
2021 Q4	–	Hold	0	–	-$24K	–	3306
2021 Q3	–	Hold	0	–	–	–	3130

Other funds holding CNSP

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barrett & Company Providence, Rhode Island $357M AUM 22.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

HRT Financial's CNSP Position: Q3 2025 in Review

HRT Financial sold out of CNS Pharmaceuticals (CNSP) in Q3 2025, closing a stake of 905 shares — an estimated $8K sold.

HRT Financial first reported a position in CNSP in Q1 2024 and held it in 3 quarters. The position peaked at $18K in Q4 2024. 8 funds tracked by Wall St. Rank hold CNSP as of Q3 2025.

HRT Financial reported no remaining CNS Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
HRT Financial sold 905 CNS Pharmaceuticals shares in Q3 2025, an estimated $8K.
HRT Financial first reported a position in CNS Pharmaceuticals in Q1 2024 and held it in 3 quarters.
HRT Financial's CNS Pharmaceuticals position peaked at $18K in Q4 2024.
8 funds tracked by Wall St. Rank held CNS Pharmaceuticals as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.